68Ga-NODAGA-RGD
Showing 1 - 25 of 463
Pathological Angiogenesis Trial in Lausanne (68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, 18F-FET PET/CT)
Recruiting
- Pathological Angiogenesis
- 68Ga-NODAGA-RGD PET/CT
- +2 more
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois, Nuclear Medicine
Jun 11, 2022
Myocardial Infarction, Acute, Myocardial Reperfusion, Chronic Ischemic Heart Disease Trial in Lausanne (68Ga-NODAGA-RGD PET/CT,
Recruiting
- Myocardial Infarction, Acute
- +2 more
- 68Ga-NODAGA-RGD PET/CT
- 82-Rb PET/CT as part of standard care, not a comparator
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois
Jun 11, 2022
Coronary Artery Disease Trial in Turku, Leiden, Lausanne (68Ga-NODAGA-RGD PET-imaging)
Recruiting
- Coronary Artery Disease
- 68Ga-NODAGA-RGD PET-imaging
-
Turku, Finland
- +2 more
Mar 20, 2022
Chronic Ischemic Heart Disease Trial in Copenhagen (68Ga-NODAGA-E[c(RGDyK)]2)
Not yet recruiting
- Chronic Ischemic Heart Disease
-
Copenhagen, Region Hovedstaden, DenmarkDepartment of Physiology, Nuclear Medicine and PET
Jun 7, 2021
Neuroendocrine Tumors Trial in Beijing (Al18F-NOTA-LM3, 68Ga-DOTATATE, 68Ga-NODAGA-LM3)
Recruiting
- Neuroendocrine Tumors
- Al18F-NOTA-LM3
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 20, 2023
Neuroendocrine Tumors Trial in Copenhagen (One injection of 68Ga-NODAGA-E[c(RGDyK)]2, PET/CT)
Completed
- Neuroendocrine Tumors
- One injection of 68Ga-NODAGA-E[c(RGDyK)]2
- PET/CT
-
Copenhagen, DenmarkDepartment of Clinical Physiology, Nuclear Medicine and PET, Rig
Jun 28, 2022
Tumor Trial in Fuzhou (68Ga-FAP-RGD)
Recruiting
- Tumor
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Aug 23, 2022
Lung Tumors Trial in Beijing (68Ga-FAPI-RGD, 18F-FDG, 68Ga-FAPI)
Recruiting
- Lung Neoplasms
- 68Ga-FAPI-RGD
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 13, 2022
Breast Cancer, Prostate Cancer, Brain Tumor Trial in Beijing (68Ga-RM26-RGD, 18F-FDG, 68Ga-RM26)
Recruiting
- Breast Cancer
- +3 more
- 68Ga-RM26-RGD
- +3 more
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 18, 2022
Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)
Recruiting
- Tumor, Solid
- Positron-Emission Tomography
- 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
-
Xiamen, Fujian, ChinaThe First Affiliated Hospital of Xiamen University
Sep 16, 2022
Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and
Not yet recruiting
- Von Hippel-Lindau Disease
- 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
- (no location specified)
Mar 30, 2023
Solid Tumor Trial in Suzhou (68Ga-NODAGA-SNA006)
Recruiting
- Solid Tumor
- 68Ga-NODAGA-SNA006
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 8, 2022
Keloid Trial in Beijing (68Ga-FAPI, (68)Ga-RGD)
Recruiting
- Keloid
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 2, 2022
Acute Myocardial Infarction Trial in Copenhagen (68Ga-NODAGA-E[c(RGDyK)]2)
Completed
- Acute Myocardial Infarction
-
Copenhagen, Region Hovedstaden, DenmarkDepartment of Physiology, Nuclear Medicine and PET
Jul 13, 2020
Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)
Recruiting
- Lung Cancer
- Neuroendocrine Neoplasm
-
Beijing, Beijing, ChinaPeking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022
Exendin PET/CT for Imaging of Paragangliomas
Recruiting
- Paraganglioma
- 68Ga-NODAGA-exendin-4 PET/CT
-
Nijmegen, NetherlandsRadboud University Medical Center
Jun 13, 2022
Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)
Recruiting
- Diabetes Mellitus
- 68Ga-NODAGA-exendin-4 PET/CT
-
Vienna, Austria
- +1 more
Jun 16, 2022
Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)
Recruiting
- Type 1 Diabetes
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Center
Nov 17, 2022
RGD PET/CT Imaging in COVID-19 Patients
Completed
- Covid19
- +2 more
- [68Ga]Ga-DOTA-(RGD)2 PET/CT
-
Nijmegen, NetherlandsRadboudumc
Apr 26, 2021
Insulinoma Trial (68Ga-NODAGA-exendin 4 PET/CT)
Completed
- Insulinoma
- 68Ga-NODAGA-exendin 4 PET/CT
- (no location specified)
Jun 15, 2021
Visualizing Beta Cells After Islet Transplantation
Terminated
- Type 1 Diabetes Mellitus
- 68Ga-NODAGA-exendin PET/CT
-
Nijmegen, Gelderland, Netherlands
- +1 more
Jan 29, 2022
Gestational Diabetes Trial in Nijmegen (68Ga-NODAGA-exendin-4 PET/CT)
Recruiting
- Gestational Diabetes
- 68Ga-NODAGA-exendin-4 PET/CT
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Jun 15, 2021
Neuroendocrine Tumors Trial in Beijing (68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 PET/CT, 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 PET/CT)
Recruiting
- Neuroendocrine Tumors
- 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 PET/CT
- 68Ga-NODAGA-LM3 and 68Ga-NODAGA-JR11 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 3, 2020
Diabetes, Type 2 Trial in Nijmegen (Ga-68-NODAGA-exendin-4 PET/CT)
Recruiting
- Diabetes Mellitus, Type 2
- Ga-68-NODAGA-exendin-4 PET/CT
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Oct 8, 2020
Metastatic Melanoma Trial in Lausanne (TIL, Cyclophosphamide, Fludarabine)
Active, not recruiting
- Metastatic Melanoma
- TIL
- +4 more
-
Lausanne, Vaud, SwitzerlandCHUV Oncology Department
Oct 11, 2021